IRCT2016053028182N1
Completed
Phase 3
The effectiveness of memantin in the treatment of adult with attention deficit hyperactivity disorder
Kurdistan University of Medical science0 sites40 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Adult ADHD (Attention-deficit hyperactivity disorder ).
- Sponsor
- Kurdistan University of Medical science
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •receiving DSM\-IV\-TR diagnostic criteria for ADHD; the age range of 18 to 45 years old; not using any psychiatric drugs at least 2 weeks before the research. Exclusion criteria: having mental retardation; having any psychiatric disorders except Oppositional Defiant disorder; allergic history to Memantine; having serious disorder like heart disease; uncontrolled Seizure disorder; individuals with Systolic blood pressure above 125 mmHg or resting pulse under 60 or having above 115 beats per minute: Pregnant and lactating women
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Assessment the effect of memantine in the treatment of chemotherapy-induced peripheral neuropathychemotherapy-induced peripheral neuropathy in patients with cancer.Idiopathic peripheral autonomic neuropathyG90.0IRCT20160310026998N12Tabriz University of Medical Sciences180
Completed
Phase 2
Memantine in the treatment of obsessive-compulsive disorderIRCT201106031556N22Tehran University of Medical Sciences40
Completed
Phase 2
Memantine effect in the treatment of residual symptoms in patients with schizophreniaIRCT2017013032236N2Vice chancellor for research, Mazandaran University of Medical Sciences50
Recruiting
Not Applicable
Memantine for treatment of Obsessive-Compulsive DisorderIRCT20170123032145N4Iran University of Medical Sciences44
Not yet recruiting
Phase 3
The effectiveness of the combination of Memantine and Betahistine on insomnia severity, quality of life and severity of symptoms in people with primary tinnitusIRCT20190427043389N4Zanjan University of Medical Sciences60